Table 1.
Treatment | Model | Term | Age (weeks) | Regenerative cellsa | Graft | % Engraftment | References |
---|---|---|---|---|---|---|---|
Acetaminophen (paracetamol) | Mouse | Acute | 4–6 | VAL9 hESCs, hiPSC derived cells | 1 × 106 GFP-labeled VAL-Hep, intrasplenic | 10.2, at day 30 post-Tx | [18, 44] |
2-Acetylaminofluorine | Rat | Chronic | 7–8 | HPCs, WB-F344 | – | – | [192] |
Carbon tetrachloride | Mouse | Acute | ND | LPCs | – | – | [44] |
Diethoxycarbonyl-1,4-dihydro-collidin (DDC)-diet | Mouse | Chronic | ND | HNF1β+ | – | – | [44] |
Choline-deficient ethionine-supplemented (CDE)-diet | Mouse | Chronic | ND | HNF1β+ | – | – | [44] |
Atherogenic + high fat dietb | Mouse | Chronic | 8 | HCs | 1 × 105 GFP-Tg ADSCs, intrasplenic | Detected ≤ 2 weeks in liver post-Tx | [67] |
Tamoxifen | Mouse | Chronic | ND |
GFP+HNF4+ CK19− HCs. YFP+CK19− HNF4α+ periportal HCs HybHPc |
– | Tracked for 9 months | [31] |
Diethylnitrosamine | Mouse | Chronic | 6–9 | hESC/iPSC-derived HCs | 0.1–2 × 106 hESC/iPSC-derived HLCs, i.v. | 2–17% in the liver, 8 weeks post-Tx | [111] |
Retrorsine + PHx | Rat | Acute | 4 | HCs | 5 × 106 HCs, intrasplenic | Detected ≤ 2 weeks in liver post-Tx | [39, 68] |
Mouse | Acute | ND | HCs, MSCs | 2 × 106 hu fetal HCs and/or hFLMSC | Co-Tx 81,000/mm3 liver | [72] | |
Monocrotaline | Rat | Acute | 8–10 | DPPIV+ HCs | 1 × 107 fresh DPPIV+ HCs, intrasplenic | ≤ 1000 cells/50 consecutive liver lobules 3 months post Tx | [193] |
Irradiation + PHx | Rat | Acute | 7–8 | HCs + fibroblasts | Co-Tx fibroblast + multilayered HCs sheets, s.c. | Detected 2 months post-Tx | [69] |
HCV | Mouse | Chronic | 5–8 months | hESCs- and hiPSCs-derived HLCs | 4 × 106 HLCs, intrasplenic | – | [194] |
Ganciclovir | Mouse | Chronic | 7–8 | Endothelial | 12 EGFP- or KO1-hiPSC-LB on the mesentery | – | [145] |
Diphtheria toxin | 3–4 × 106 hu HCs under kidney capsule | – | |||||
Thioacetamide | Mouse | Acute | 7–8 | ADMSC, HLCs, CK8+ | 5 × 106 EGFP-labeled ADMSC, intrasplenic or i.v. | Detected ≤ 4 weeks in liver post-Tx | [126] |
Phenobarbital + CCl4 | Rat | Chronic | 38 | – | – | – | [67] |
Galactosamine | Rat | Acute | 8–10 | – | 8.8–10.5 × 106 HC, i.p. | 1 week post-Tx | [174] |
ADMSC adipose-derived mesenchymal stem cells, HC hepatocytes, HLC hepatocyte-like cell, HPCs hepatic progenitor cells, HybHP hybrid hepatocytes, hiPSC-LB human induced pluripotent stem cells-liver buds, s.c. subcutaneously, i.p. intraperitoneal, i.v. intravenous, Tx transplantation, EGFP enhanced green fluorescent protein or human Kusabira-Orange (KO1) for live imaging [126], hFLMSC human fetal liver mesenchymal stem cells, ND or (–) non determined, DPPIV dipeptidyl peptidase IV
aThe cell populations that are involved in liver regeneration per experiment
bComposed of cocoa butter, cholesterol, cholate, and corticotropin-releasing factor-1
cHybHP have an elevated Sox9 promoter activity and expression of other ductal markers were studied in Sox9-Cre ERT ;R26R tdTomato mice